MRNA Operating Income History: $-3.07B (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	−$1.4B−32.2%	Not reported	Not reported	Not reported
FY25	−$1.1B+17.1%	−$907M+33.5%	−$260M−271.4%	−$857M+31.2%
FY24	−$1.3B−245.9%	−$1.4B+27.0%	−$70M+96.5%	−$1.2B−20866.7%
FY23	−$366M−108.7%	−$1.9B−176.3%	−$2.0B−272.6%	$6M−99.6%
FY22	$4.2B+233.9%	$2.4B−20.1%	$1.2B−67.2%	$1.6B−70.8%
Share	27%	25%	20%	29%

01—History

Operating Income History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

−$3.07B

YoY changeLargest recent move−39.7%in FY20Latest +22.1%

1 older move runs past ±150% (largest +1842.6%); point at, tap or drag across the bars to read one.

02—Ledger

Operating Income, period by period

Period	Value	Change	Source
FY2025	−$3.07B	+22.1%	10-K
FY2024	−$3.94B	+6.9%	10-K
FY2023	−$4.24B	−145.0%	10-K
FY2022	$9.42B	−29.2%	10-K
FY2021	$13.30B	+1842.6%	10-K
FY2020	−$763.0M	−39.7%	10-K
FY2019	−$546.0M	−32.1%	10-K
FY2018	−$413.3M	−53.4%	10-K
FY2017	−$269.4M	−20.4%	10-K
FY2016	−$223.8M	—	10-K

03—Questions

What is operating income?

Operating income can be defined as profit from core business operations, calculated as gross profit minus operating expenses, before interest and taxes.

What is Moderna, Inc.'s current operating income?

Moderna, Inc. (MRNA) annual operating income for 2025 was $-3.07B, a 22.08% increase from 2024. Moderna, Inc. operating income for the quarter ending March 31, 2026 was $-1.39B.

What was Moderna, Inc.'s operating income in 2024?

Moderna, Inc. annual operating income for 2024 was $-3.94B, a 6.94% increase from 2023.

What was Moderna, Inc.'s operating income in 2023?

Moderna, Inc. annual operating income for 2023 was $-4.24B, a 145.00% decline from 2022.

Company: Moderna, Inc.
Ticker: MRNA
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Moderna, Inc. Operating Income 2016-2026 | MRNA

Key Statistics